China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Statistics

Total Valuation

SXTC has a market cap or net worth of $186.80 million. The enterprise value is $169.55 million.

Market Cap	186.80M
Enterprise Value	169.55M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SXTC has 116.03 million shares outstanding. The number of shares has increased by 1,212.67% in one year.

Current Share Class	116.03M
Shares Outstanding	116.03M
Shares Change (YoY)	+1,212.67%
Shares Change (QoQ)	+504.74%
Owned by Insiders (%)	35.33%
Owned by Institutions (%)	0.02%
Float	75.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.32
Forward PS	n/a
PB Ratio	1.44
P/TBV Ratio	12.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	97.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.06.

Current Ratio	3.54
Quick Ratio	3.33
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.21

Financial Efficiency

Return on equity (ROE) is -22.50% and return on invested capital (ROIC) is -9.84%.

Return on Equity (ROE)	-22.50%
Return on Assets (ROA)	-7.48%
Return on Invested Capital (ROIC)	-9.84%
Return on Capital Employed (ROCE)	-17.13%
Revenue Per Employee	$23,212
Profits Per Employee	-$44,049
Employee Count	75
Asset Turnover	0.08
Inventory Turnover	1.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.65% in the last 52 weeks. The beta is 1.25, so SXTC's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	-80.65%
50-Day Moving Average	1.70
200-Day Moving Average	2.70
Relative Strength Index (RSI)	48.64
Average Volume (20 Days)	74,078

Short Selling Information

Short Interest	72,752
Short Previous Month	49,126
Short % of Shares Out	0.06%
Short % of Float	n/a
Short Ratio (days to cover)	1.08

Income Statement

In the last 12 months, SXTC had revenue of $1.74 million and -$3.30 million in losses. Loss per share was -$2.32.

Revenue	1.74M
Gross Profit	367,427
Operating Income	-2.68M
Pretax Income	-14.14M
Net Income	-3.30M
EBITDA	-2.60M
EBIT	-2.68M
Loss Per Share	-$2.32

Balance Sheet

The company has $18.24 million in cash and $983,877 in debt, giving a net cash position of $17.25 million or $0.15 per share.

Cash & Cash Equivalents	18.24M
Total Debt	983,877
Net Cash	17.25M
Net Cash Per Share	$0.15
Equity (Book Value)	15.44M
Book Value Per Share	1.12
Working Capital	15.28M

Cash Flow

In the last 12 months, operating cash flow was -$2.35 million and capital expenditures -$2,023, giving a free cash flow of -$2.35 million.

Operating Cash Flow	-2.35M
Capital Expenditures	-2,023
Free Cash Flow	-2.35M
FCF Per Share	-$0.02

Margins

Gross margin is 21.11%, with operating and profit margins of -153.97% and -189.77%.

Gross Margin	21.11%
Operating Margin	-153.97%
Pretax Margin	-189.77%
Profit Margin	-189.77%
EBITDA Margin	-149.24%
EBIT Margin	-153.97%
FCF Margin	n/a

Dividends & Yields

SXTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,212.67%
Shareholder Yield	-1,212.67%
Earnings Yield	-1.77%
FCF Yield	-1.26%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 25, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date	Feb 25, 2025
Split Type	Reverse
Split Ratio	1:8

Scores

SXTC has an Altman Z-Score of -1.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.03
Piotroski F-Score	4